NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDIsatuximab SARCLISA®
(20mg/mL concentrate for solution for infusion) 		Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Isatuximab Isatuximab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA 658 Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma
NICE TA1098: Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable
NICE TA658: Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma